Similar to this unsustained therapeutic effect in viral infection models, an anti-PD-L1 mAb was shown to have only transient antitumor effects in a mouse model, in contrast to the complete suppression of myeloma growth by gene knockout of PD-1 (85). The gene discussed is CD274; the disease is plasma cell myeloma.